Detalhe da pesquisa
1.
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.
Ann Oncol
; 33(1): 57-66, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34624497
2.
Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial.
Ann Oncol
; 29(8): 1793-1799, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873684
3.
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.
Ann Oncol
; 28(4): 824-830, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031175
4.
Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].
Ann Oncol
; 33(4): 454, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086737
5.
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.
Ann Oncol
; 27(7): 1273-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27091810
6.
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study).
Ann Oncol
; 25(5): 1018-25, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24585720
7.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol
; 25(12): 2378-2385, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25294886
8.
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study.
Ann Oncol
; 24(6): 1560-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23493136
9.
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib).
Pharmacogenomics J
; 13(5): 410-6, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22664478
10.
[Diagnosis of and therapy for hepatocellular carcinoma]. / Diagnostik und Therapie des hepatozellulären Karzinoms.
Z Gastroenterol
; 51(11): 1269-326, 2013 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-24243572
11.
Geriatric assessment and the variance of treatment recommendations in geriatric patients with gastrointestinal cancer-a study in AIO oncologists.
ESMO Open
; 8(1): 100761, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638708
12.
Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials.
Br J Cancer
; 107(7): 1044-50, 2012 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910317
13.
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.
ESMO Open
; 6(5): 100242, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482179
14.
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Br J Cancer
; 102(3): 500-5, 2010 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20068568
15.
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.
Br J Cancer
; 100(1): 44-9, 2009 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-19066607
16.
[Comparing immunohistochemical diagnosis of cancer of unknown primary with gene expression-based tumor classification]. / Vergleich immunhistologischer mit genexpressionsbasierter Diagnostik: von Karzinomen mit unbekanntem Primarius.
Pathologe
; 30 Suppl 2: 168-72, 2009 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-19756615
17.
An optimized targeted Next-Generation Sequencing approach for sensitive detection of single nucleotide variants.
Biomol Detect Quantif
; 15: 6-12, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29349042
18.
Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3.
Eur J Cancer
; 88: 77-86, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29195117
19.
FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL study.
Eur J Surg Oncol
; 42(10): 1540-7, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27575968
20.
[Principles of postoperative therapy in rectal carcinoma]. / Prinzipien der postoperativen Therapie beim Rektumkarzinom.
Chirurg
; 75(1): 32-7, 2004 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-14740125